Navigation Links
Boston Scientific Announces FDA Approval of New Heart Failure Lead
Date:5/16/2008

, enabling wireless remote management of patients.

"This study demonstrates Boston Scientific's commitment to quality and robust post-market surveillance of new leads," said Arjun Sharma, M.D., Vice President, Patient Safety, Boston Scientific CRM. "The data from this post- market study will provide us with a deeper understanding of the lead's performance in real-world practice and will be a welcome addition to the data we collected from the U.S. clinical trial."

Boston Scientific is the only company to offer four fixation designs that provide stability in a variety of venous anatomies, enabling physicians to select the most appropriate lead for their patients. The ACUITY Spiral lead is designed for use with heart failure devices, such as the COGNIS(TM) CRT-D, which received FDA approval earlier this week.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our product performance, regulatory approval of our products, new product launches, competitive offerings, our growth strategy, and our market position. If our underlying assumptions turn out to be incorrect, or if certain r
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
2. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
3. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
4. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
5. Fraunhofer and Boston University Hosted Prestigious SME Tour
6. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
7. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
8. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
9. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
10. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
11. Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
..., Jolanta Kolodziejek, MSc, and Professor ... Group, Institute of Virology, University of Veter...z 1, A 1210 Vienna, Austria , , ... template employed in sequencing PCR (cycle sequen...cleotide sequencing. The presence of , co...
..., Anne-Lise Brresen-Dale, Sigrid Lystad, a...ute for Cancer Research, The,Norwegian Radium Ho...ion , Temporal temperature gradient ele... upon which denaturing gradient gel electropho...l electrophoresis (CDGE) are based. TTGE combines ...
..., Udo Reischl and Christian Gerdes, Instit...ity of Regensburg, 93053 Regensburg, Germany , ...nosis of Epstein-Barr virus (EBV) infection is cur...dies to distinct EBV antigens. In the past few ,...erodiagnostic assay systems , have been c...
..., , Introduction , ... year for use as primers , or probes in g...ions has , traditionally been done by sla... methods may require expensive reagents and labor...ired quantitative precision or automation. Capilla...
Other Biology Technology:Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 2Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 3Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 4TTGE on the DCode System 2TTGE on the DCode System 3TTGE on the DCode System 4Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 2Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 3Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 4Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 5Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 6Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 7Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 8Oligonucleotide Purity Analysis by Capillary Electrophoresis 2Oligonucleotide Purity Analysis by Capillary Electrophoresis 3
(Date:7/24/2008)...am led by Massachusetts General Hospital (MGH) inv...enomic research and medicine a robust method for ...cular DNA sequences for inactivation or repair. ...archers describe an efficient, publicly available ...s (ZFNs), which can be used to induce specific gen...
(Date:7/24/2008)...dy by researchers from Columbia University,s Mailm...st challenging issues in infant health and prevent...ries. In these settings, HIV-infected mothers had...infants, they should exclusively breast-feed, foll...irth. But according to the study conducted in Lusa...
(Date:7/24/2008)...ine researchers have found a molecular link betwee...olism. The discovery reveals new possibilities for...ted diseases. , Paolo Sassone-Corsi, Distinguish...lleagues have identified that an essential protein...rhythms, works in balance with another protein cal...
(Date:7/24/2008)...2008. A fire is currently burning through a study ...or about 2 years ago. Managers used data and analy...R) study in the planning, analysis, and implementa...e is now active., The Gotchen LSR, lies on the e...covers about 15,000 acres of the Mount Adams Range...
Breaking Biology News(10 mins):Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2From beach to backyard caution can reduce firepit burns 22960 1From beach to backyard caution can reduce firepit burns 22960 2New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 1New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 2New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 3New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 4Tree killing fungus officially named by scientists 3819 1Tree killing fungus officially named by scientists 3819 2Robbins 26 Myers Issues Corrected Conference Call Information 22958 1
...e caused by arterial blockages related to diabetes...ns ?are occurring at an alarming rate. Yet physici...them may be preventable, according to the Internat...nly disfiguring and life-threatening, but are more...on, which is the reestablishment of blood supply. ...
...SX: NRM) is pleased to announce that Neurobiology ... medical journals in the fields of gerontology and...a publication on the preclinical development of tr...ed?, including efficacy results in a mouse model o...sents a potential new class of therapeutic agent a...
...y Professor of Psychology Dr. Jeffrey Mogil shows ...d but unproven even among higher primates, is also... online June 29 in the journal Science, Professor ...lleagues in the Pain Genetics Lab at McGill Univer...t is, familiar to each other) and able to see one ...
...f Texas M. D. Anderson Cancer Center have signific...a cell begins the process of self-destruction - an...argeted cancer therapies. , , In the June 30 is...hat a natural "brake" exists in a cell to prevent ...eath, and they say that optimal anti-cancer therap...
Other Biology News:Epidemic of unneeded amputations 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 3Researchers find molecular 'brake' to cell death 2Researchers find molecular 'brake' to cell death 3
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7.
ASCIZ
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID:
Custom Oligo Assay Single Locus 1920 samples from Illumina
Biology Products: